US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.15

-0.0133-0.06%

Volume:494

Turnover:11.43K

Market Cap:4.63M

PE:- -

High:23.15

Open:23.12

Low:23.12

Close:23.16

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.63

T/O Rate:0.25%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Central Bank of India Sells US Dollars in Forex Market to Bolster Rupee, According to Traders

South African Fund Manager with $47 Billion AUM Reduces AI Chip Holdings, Boosts Exposure to Indian Equities

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models

HBM Holdings Wins NMPA IND Nod for Long-Acting Asthma Antibody HBM7575

ABBISKO-B Surges Over 5% on FDA Clearance for Investigational Drug Application of Oral Pan-KRAS Inhibitor

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

Atrium Therapeutics announces FDA clearance of ATR 1072 IND application

HAIXI PHARMA's HXP089 Project Receives NMPA Approval for Glioblastoma Clinical Trial Application

Haisco Pharmaceutical's China IND Application for Novel Inflammatory Drug Accepted

MT Newswires Live

Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy

Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026

Market Participants Report Indian Central Bank's Dollar Sales to Support Rupee

Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211

Global funds return to Indian stocks with US$1 bil in buying

Ashutosh Joshi / Bloomberg

India Ratings Upgrades Vadilal Industries’ Credit Profile to IND A+

Shanghai Henlius Biotech's Cancer Drug Combination Trial Gets IND Approval

MT Newswires Live

Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application

UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IND/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.145,"timestamp":1788206400000,"preClose":23.1583,"halted":0,"volume":494,"delay":0,"changeRate":-0.0005743081314259241,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Pre-Mkt","change":-0.0133,"latestTime":"09-01 08:06:05 EDT","open":23.115,"high":23.145,"low":23.115,"amount":11430,"amplitude":0.001295,"askPrice":24,"askSize":19,"bidPrice":9.26,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":23.145,"sharesOutstanding":200001,"nav":23.107,"aum":4621406.79,"dividendRate":0.003409,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.115,"preClose":23.145,"latestTime":"16:10 EDT","volume":7,"amount":162.015,"timestamp":1788207004404,"change":-0.03,"changeRate":-0.001296,"amplitude":0},"volumeRatio":0.6283389809433055},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6283389809433055,"shares":200001,"dividePrice":0.0789,"high":23.145,"amplitude":0.001295,"preClose":23.1583,"low":23.115,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.145,"committee":0.826484,"eps":0,"divideRate":0.003409,"volume":494,"delay":0,"ttmEps":0,"open":23.115,"prevYearClose":24.78,"prevWeekClose":23.1583,"prevMonthClose":23.145,"prevQuarterClose":22.88,"fiveDayClose":23.065,"twentyDayClose":23.01,"sixtyDayClose":22.2234},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127672518","title":"Central Bank of India Sells US Dollars in Forex Market to Bolster Rupee, According to Traders","url":"https://stock-news.laohu8.com/highlight/detail?id=1127672518","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127672518?lang=en_us&edition=fundamental","pubTime":"2026-07-20 12:00","pubTimestamp":1784520022,"startTime":"0","endTime":"0","summary":"According to traders with knowledge of the matter, the Reserve Bank of India has been selling US dollars in both offshore and onshore foreign exchange markets to support the rupee. These traders...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPI","INDL","SMIN","NFTY","FLIN","FLIBF","INDE","IOPP","PIN","NDIA","INDA","SCIN","UDN","IND","INQQ","BK4523","UUP","BK4588","INCO","BK4585","IMVP","INDY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117398250","title":"South African Fund Manager with $47 Billion AUM Reduces AI Chip Holdings, Boosts Exposure to Indian Equities","url":"https://stock-news.laohu8.com/highlight/detail?id=1117398250","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117398250?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:52","pubTimestamp":1784278327,"startTime":"0","endTime":"0","summary":"A South African asset manager overseeing $47 billion has trimmed its investments in semiconductor manufacturers and increased its allocation to the Indian market, as market expectations for...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEMX","XSOE","QLVE","MEMX","ASIA","AIBU","EEMA","AIVC","PIN","SEEM","HEEM","INDY","AIS","INDL","AVS","WISE","FEMR","RWEM","BBEM","AVGG","INQQ","EMXC","EEMV","QEMM","EPI","BKF","BCHI","NDIA","XC","EET","BK4585","AVEM","LRNZ","MEM","SCHE","STXE","BK4588","BKEM","DFAE","AVL","EQLT","IMVP","XCEM","NFTY","MFEM","SPEM","XXCH","ALAI","SCIN","SMIN","AIFD","IND","GLIN","INDH","INDE","IOPP","XCNY","DEXC","VEU","FLIBF","FAI","BK4523","INDA","INCO","AVGW","AVGX","AVGU","KEMX","FLIN","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651464104","title":"OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2651464104","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651464104?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:00","pubTimestamp":1784199600,"startTime":"0","endTime":"0","summary":"New client programme to be supported from OXB’s FDA-approved, commercial scale viral vector manufacturing facility in Durham, North Carolina, underscoring increasing global demand for OXB’s end-to-end","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/16/3328316/0/en/OXB-Selected-as-GMP-Manufacturing-Partner-to-Support-Manufacturing-of-Plowshare-Therapies-AAV-Gene-Therapy-Programme.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EES","JDOC","IND","SYNB","BK4585","CDMO","IBB","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651246501","title":"Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2651246501","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651246501?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:05","pubTimestamp":1784120700,"startTime":"0","endTime":"0","summary":"Data show clade IIb from 2022 outbreak is 100 to 100,000-fold less virulent than clade IIa from 2003 outbreak  Three new models for investigating mpox infection and pathogenesis identified Tonix is ad","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/15/3327818/28908/en/Tonix-Pharmaceuticals-Announces-Publication-in-the-Peer-Reviewed-Journal-of-Virology-Assessing-Virulence-of-the-2022-Outbreak-Strain-of-Mpox-in-New-Animal-Models.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","RDC","BK4135","BK4583","BK4139","BK4188","IND","ASM","TNXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651454611","title":"HBM Holdings Wins NMPA IND Nod for Long-Acting Asthma Antibody HBM7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2651454611","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651454611?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:07","pubTimestamp":1784110075,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. ( ($HK:2142) ) just unveiled an announcement. HBM Holdings Ltd. reported that China’s National Medical Products Administration ha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hbm-holdings-wins-nmpa-ind-nod-for-long-acting-asthma-antibody-hbm7575?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hbm-holdings-wins-nmpa-ind-nod-for-long-acting-asthma-antibody-hbm7575?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRAL","HBM","MUD","RAM","DRAM","MULL","MUU","BK4168","IND","COPP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140504842","title":"ABBISKO-B Surges Over 5% on FDA Clearance for Investigational Drug Application of Oral Pan-KRAS Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1140504842","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140504842?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:26","pubTimestamp":1784085985,"startTime":"0","endTime":"0","summary":"Shares of ABBISKO-B (HKEX: 02256) have risen by more than 5%. At the time of writing, the stock is up 5.53% to HKD 11.25, with a turnover of HKD 2.5452 million.The move follows a recent company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","KCAI","LU2488822045.USD","BK1574","LU2476274308.USD","BK1161","02256","159938","BK1515","IND","LU2778985437.USD","IE00BPRC5H50.USD","BK4588","BK4585","09939","IE00B543WZ88.USD","LU2476274720.SGD","LABU","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651738105","title":"Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2651738105","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651738105?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:00","pubTimestamp":1784030400,"startTime":"0","endTime":"0","summary":"–Expands pipeline with SNDX-4321, a novel, mutant-selective, allosteric EGFR inhibitor designed to address NSCLC patient populations with significant unmet needs – –SNDX-62122, a next-generation menin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/14/3326768/0/en/Syndax-to-Highlight-Late-Stage-Programs-and-Unveil-New-Pipeline-Assets-at-R-D-Event.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651172282","title":"Atrium Therapeutics announces FDA clearance of ATR 1072 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2651172282","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651172282?lang=en_us&edition=fundamental","pubTime":"2026-07-14 18:40","pubTimestamp":1784025625,"startTime":"0","endTime":"0","summary":"Atrium Therapeutics (RNA) announced that the FDA has cleared its investigational new drug, or IND, application allowing the company to move forward...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atrium-therapeutics-announces-fda-clearance-of-atr-1072-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atrium-therapeutics-announces-fda-clearance-of-atr-1072-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATR","LABU","BK4126","BK4588","RNA","BK4585","BK4139","IE0009354923.USD","IND","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116749786","title":"HAIXI PHARMA's HXP089 Project Receives NMPA Approval for Glioblastoma Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1116749786","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116749786?lang=en_us&edition=fundamental","pubTime":"2026-07-14 17:13","pubTimestamp":1784020411,"startTime":"0","endTime":"0","summary":"The company's self-developed HXP089 project, intended for the treatment of glioblastoma (GBM), has received approval for its Investigational New Drug (IND) application from the Center for Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BMED","BK1191","IBBQ","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651127121","title":"Haisco Pharmaceutical's China IND Application for Novel Inflammatory Drug Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=2651127121","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651127121?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:09","pubTimestamp":1784005753,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical  said China's medical products regulator has accepted the investigational new drug application for HSK60002 tablets.The drug was independently developed for treating inflammatory diseases, according to a Tuesday filing with the Shenzhen bourse.Shares of the company fell 1% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0188","IND","002653","BK0028","BK0077","BK0033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651147194","title":"Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2651147194","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651147194?lang=en_us&edition=fundamental","pubTime":"2026-07-14 07:21","pubTimestamp":1783984875,"startTime":"0","endTime":"0","summary":"Neurotech International ( ($AU:NTI) ) has provided an update. Neurotech International has secured U.S. FDA clearance for its Investigational New Dr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurotech-secures-fda-ind-clearance-for-nti164-bolstering-global-asd-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurotech-secures-fda-ind-clearance-for-nti164-bolstering-global-asd-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","IND","ASD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111171","title":"Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111171","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111171?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:01","pubTimestamp":1783944060,"startTime":"0","endTime":"0","summary":"- Data presented as Developing Topics poster at AAIC 2026 - LEXINGTON, Mass., July  13, 2026  (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to levera","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326162/36461/en/Voyager-Demonstrates-Single-IV-Dose-of-VY1706-Well-Tolerated-Reduced-Tau-in-6-Month-GLP-Toxicology-Study-Initiation-of-Clinical-Trial-in-Alzheimer-s-Disease-Expected-H2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4110","BK4132","BK4590","IDNA","IND","CNS","AAIC","MEDX","GLP","BK4135","BK4144","AD","BK4225","HYLG","BBB","NHP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133045648","title":"Market Participants Report Indian Central Bank's Dollar Sales to Support Rupee","url":"https://stock-news.laohu8.com/highlight/detail?id=1133045648","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133045648?lang=en_us&edition=fundamental","pubTime":"2026-07-13 12:50","pubTimestamp":1783918242,"startTime":"0","endTime":"0","summary":"According to multiple unnamed trading sources with knowledge of the matter, the Reserve Bank of India has been selling dollars in the onshore foreign exchange market to bolster the rupee's value. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","INDY","INDE","INDL","IND","INQQ","INDA","NFTY","UDN","NDIA","EPI","IMVP","UUP","FLIN","SCIN","INCO","IOPP","BK4523","PIN","SMIN","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651207161","title":"Abbisko Wins FDA IND Clearance for Pan-KRAS Cancer Drug ABSK211","url":"https://stock-news.laohu8.com/highlight/detail?id=2651207161","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651207161?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:08","pubTimestamp":1783901304,"startTime":"0","endTime":"0","summary":"Abbisko Cayman Limited ( ($HK:2256) ) has issued an update. Abbisko Therapeutics has received clearance from the U.S. Food and Drug Administration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-ind-clearance-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbisko-wins-fda-ind-clearance-for-pan-kras-cancer-drug-absk211?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146902","title":"Global funds return to Indian stocks with US$1 bil in buying","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146902","media":"Ashutosh Joshi / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146902?lang=en_us&edition=fundamental","pubTime":"2026-07-13 06:09","pubTimestamp":1783894143,"startTime":"0","endTime":"0","summary":"Foreign investors poured more than US$1 billion into Indian equities last week.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/india/global-funds-return-indian-stocks-us1-bil-buying?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/india/global-funds-return-indian-stocks-us1-bil-buying?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["SCIN","NFTY","INDY","BK4588","PIN","FLIN","INDL","EPI","SMIN","BK4585","BK4523","INDA","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650139262","title":"India Ratings Upgrades Vadilal Industries’ Credit Profile to IND A+","url":"https://stock-news.laohu8.com/highlight/detail?id=2650139262","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650139262?lang=en_us&edition=fundamental","pubTime":"2026-07-10 23:54","pubTimestamp":1783698887,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Vadilal Industries Limited ( ($IN:VADILALIND) ). India Ratings and Research has upgraded Vadilal Industries Lim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-vadilal-industries-credit-profile-to-ind-a?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-upgrades-vadilal-industries-credit-profile-to-ind-a?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNDmain","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650518161","title":"Shanghai Henlius Biotech's Cancer Drug Combination Trial Gets IND Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2650518161","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650518161?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:12","pubTimestamp":1783678326,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (HKG:2696) said its investigational new drug application for a Phase I clinical trial of HLX37 in combination with chemotherapy or HLX43 has been approved by China's National ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000306685.HKD","BK4588","BK4585","XBI","HK0000306701.USD","HK0000320223.HKD","02696","HK0000320264.USD","IND","BK1161","HK0000165453.HKD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650922495","title":"Quoin Pharmaceuticals announces FDA clearance of QRX003 IND application","url":"https://stock-news.laohu8.com/highlight/detail?id=2650922495","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650922495?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:16","pubTimestamp":1783602970,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced that the FDA has cleared the company’s investigational new drug, or IND, application for QRX003 for the trea...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-announces-fda-clearance-of-qrx003-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-announces-fda-clearance-of-qrx003-ind-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4588","BK4139","LABU","BK4585","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996159","title":"UroGen Announces FDA Clearance of the IND for UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996159","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996159?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512000,"startTime":"0","endTime":"0","summary":"FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient enrollment expected to begin in Q4 2026UGN-501 is a different","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324037/0/en/UroGen-Announces-FDA-Clearance-of-the-IND-for-UGN-501-an-Investigational-Next-Generation-Oncolytic-Virus-for-Non-Muscle-Invasive-Bladder-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996156","title":"Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996156","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996156?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:00","pubTimestamp":1783512000,"startTime":"0","endTime":"0","summary":"-- Arbitration tribunal declared that PM647 is within Prime Medicine’s “Field”, confirming Prime Medicine’s right to develop and commercialize PM647 in AATD --  -- Prime Medicine owes no monetary dama","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3324031/0/en/Prime-Medicine-Announces-Positive-Resolution-to-Arbitration-with-Beam-Therapeutics.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","CTA","BK4139","BK4539","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}